Literature DB >> 9525664

A cytopathogenic, apoptosis-inducing variant of hepatitis A virus.

K Brack1, W Frings, A Dotzauer, A Vallbracht.   

Abstract

A cytopathogenic variant of hepatitis A virus (HAV(cyt/HB1.1)) was isolated from persistently infected BS-C-1 cells by serial passages in FRhK-4 cells. This virus shows a rapid replication pattern and high final titers are obtained, which are main characteristics of cytopathogenic HAVs. Sequencing of the nontranslated regions and the coding regions for 2ABC and 3AB revealed that mutations are distributed all over these regions and that certain mutated sites correspond to those in other cytopathogenic HAV variants. Investigating the mechanisms causing the cytopathic effect in FRhK-4 cells infected with this variant, we found that an apoptotic reaction takes place.

Mesh:

Substances:

Year:  1998        PMID: 9525664      PMCID: PMC109820     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Proteolytic processing of picornaviral polyprotein.

Authors:  A C Palmenberg
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

2.  Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.

Authors:  S M Lemon; P C Murphy; P A Shields; L H Ping; S M Feinstone; T Cromeans; R W Jansen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 3.  Mitochondrial control of apoptosis.

Authors:  G Kroemer; N Zamzami; S A Susin
Journal:  Immunol Today       Date:  1997-01

4.  Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus.

Authors:  A M Nasser; T G Metcalf
Journal:  Appl Environ Microbiol       Date:  1987-12       Impact factor: 4.792

Review 5.  Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis.

Authors:  J C Ameisen; A Capron
Journal:  Immunol Today       Date:  1991-04

Review 6.  The control of apoptosis in mammalian cells.

Authors:  M K Collins; A Lopez Rivas
Journal:  Trends Biochem Sci       Date:  1993-08       Impact factor: 13.807

7.  Mutations in the 3A genomic region of two cytopathic strains of hepatitis A virus isolated in Italy.

Authors:  G Morace; G Pisani; F Beneduce; M Divizia; A Panà
Journal:  Virus Res       Date:  1993-05       Impact factor: 3.303

8.  Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene.

Authors:  B Levine; Q Huang; J T Isaacs; J C Reed; D E Griffin; J M Hardwick
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

9.  Proteins specifically binding to the 3' untranslated region of hepatitis A virus RNA in persistently infected cells.

Authors:  J P Nüesch; M Weitz; G Siegl
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency.

Authors:  E S Razvi; R M Welsh
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more
  16 in total

1.  Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle.

Authors:  V I Agol; G A Belov; K Bienz; D Egger; M S Kolesnikova; L I Romanova; L V Sladkova; E A Tolskaya
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA.

Authors:  Kerstin Brack; Iris Berk; Thomas Magulski; Jörg Lederer; Andreas Dotzauer; Angelika Vallbracht
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Authors:  Anne-Sophie Gosselin; Yannick Simonin; Florence Guivel-Benhassine; Vincent Rincheval; Jean-Luc Vayssière; Bernard Mignotte; Florence Colbère-Garapin; Thérèse Couderc; Bruno Blondel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  Hepatitis A Virus Genome Organization and Replication Strategy.

Authors:  Kevin L McKnight; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

5.  Poliovirus induces apoptosis in the mouse central nervous system.

Authors:  S Girard; T Couderc; J Destombes; D Thiesson; F Delpeyroux; B Blondel
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor.

Authors:  A Dotzauer; U Gebhardt; K Bieback; U Göttke; A Kracke; J Mages; S M Lemon; A Vallbracht
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.

Authors:  Volker Fensterl; Dajana Grotheer; Iris Berk; Stefanie Schlemminger; Angelika Vallbracht; Andreas Dotzauer
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Association between severity of type A hepatitis and nucleotide variations in the 5' non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions.

Authors:  K Fujiwara; O Yokosuka; T Ehata; H Saisho; N Saotome; K Suzuki; K Okita; K Kiyosawa; M Omata
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein.

Authors:  Lyudmila I Romanova; Peter V Lidsky; Marina S Kolesnikova; Ksenia V Fominykh; Anatoly P Gmyl; Eugene V Sheval; Stanleyson V Hato; Frank J M van Kuppeveld; Vadim I Agol
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

10.  Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Fumio Imazeki; Makoto Miki; Kazuyuki Suzuki; Kiwamu Okita; Eiji Tanaka; Masao Omata
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.